Walgreens Confirms $24 Billion Take-Private Deal -- Barrons.com

Dow Jones

03-07

By Liz Moyer

Walgreens Boots Alliance has confirmed a $23.7 billion deal to be acquired by the private-equity firm Sycamore Partners.

The struggling drugstore chain operator said the deal is for $11.45 a share in cash, a 29% premium to its closing price on Dec. 9, before the first media reports of a potential transaction.

With the deal, the company said it would be "better positioned to become the first choice for pharmacy, retail, and health services." It will continue to operate under Walgreens, Boots, and other brands and maintain its headquarters near Chicago.

"While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company," said CEO Tim Wentworth.

Shareholders will receive the cash for shares plus up to $3 in cash per share representing the future sale of the company's debt and equity interests in VillageMD, a health clinic business that includes Village Medical, Summit Health, and CityMD.

With the sale of the VillageMD assets, the total deal consideration is a premium of up to 63% of Walgreens' share price on Dec. 9.

Walgreens shares rose 5.7% in after hours trading on Thursday. They are up 13.6% this year on speculation that a take-private deal was coming. The shares are down 49% over the past 12 months.

Write to Liz Moyer at liz.moyer@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 06, 2025 18:15 ET (23:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2517140111"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517140111\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2517140111?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-07 07:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517140111","market":"hk","top_or_hot":-1,"title":"Walgreens Confirms $24 Billion Take-Private Deal -- Barrons.com","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Liz Moyer \n</p>\n<p>\n  Walgreens Boots Alliance has confirmed a $23.7 billion deal to be acquired by the private-equity firm Sycamore Partners. \n</p>\n<p>\n     The struggling drugstore chain operator said the deal is for $11.45 a share in cash, a 29% premium to its closing price on Dec. 9, before the first media reports of a potential transaction. \n</p>\n<p>\n     With the deal, the company said it would be \"better positioned to become the first choice for pharmacy, retail, and health services.\" It will continue to operate under Walgreens, Boots, and other brands and maintain its headquarters near Chicago. \n</p>\n<p>\n     \"While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company,\" said CEO Tim Wentworth. \n</p>\n<p>\n     Shareholders will receive the cash for shares plus up to $3 in cash per share representing the future sale of the company's debt and equity interests in VillageMD, a health clinic business that includes Village Medical, Summit Health, and CityMD. \n</p>\n<p>\n     With the sale of the VillageMD assets, the total deal consideration is a premium of up to 63% of Walgreens' share price on Dec. 9. \n</p>\n<p>\n     Walgreens shares rose 5.7% in after hours trading on Thursday. They are up 13.6% this year on speculation that a take-private deal was coming. The shares are down 49% over the past 12 months. \n</p>\n<p>\n     Write to Liz Moyer at liz.moyer@barrons.com \n</p>\n<p>\n     This content was created by Barron's, which is operated by Dow Jones &amp; Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 06, 2025 18:15 ET (23:15 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Walgreens Confirms $24 Billion Take-Private Deal -- Barrons.com</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWalgreens Confirms $24 Billion Take-Private Deal -- Barrons.com\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-03-07 07:15</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Liz Moyer \n</p>\n<p>\n  Walgreens Boots Alliance has confirmed a $23.7 billion deal to be acquired by the private-equity firm Sycamore Partners. \n</p>\n<p>\n     The struggling drugstore chain operator said the deal is for $11.45 a share in cash, a 29% premium to its closing price on Dec. 9, before the first media reports of a potential transaction. \n</p>\n<p>\n     With the deal, the company said it would be \"better positioned to become the first choice for pharmacy, retail, and health services.\" It will continue to operate under Walgreens, Boots, and other brands and maintain its headquarters near Chicago. \n</p>\n<p>\n     \"While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company,\" said CEO Tim Wentworth. \n</p>\n<p>\n     Shareholders will receive the cash for shares plus up to $3 in cash per share representing the future sale of the company's debt and equity interests in VillageMD, a health clinic business that includes Village Medical, Summit Health, and CityMD. \n</p>\n<p>\n     With the sale of the VillageMD assets, the total deal consideration is a premium of up to 63% of Walgreens' share price on Dec. 9. \n</p>\n<p>\n     Walgreens shares rose 5.7% in after hours trading on Thursday. They are up 13.6% this year on speculation that a take-private deal was coming. The shares are down 49% over the past 12 months. \n</p>\n<p>\n     Write to Liz Moyer at liz.moyer@barrons.com \n</p>\n<p>\n     This content was created by Barron's, which is operated by Dow Jones &amp; Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 06, 2025 18:15 ET (23:15 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0321505439.SGD","symbol_name":"Schroder ISF Global Dividend Maximiser A Acc SGD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2517140111","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517140111","pubTimestamp":1741302900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Walgreens Boots Alliance has confirmed a $23.7 billion deal to be acquired by the private-equity firm Sycamore Partners.The struggling drugstore chain operator said the deal is for $11.45 a share in cash, a 29% premium to its closing price on Dec. 9, before the first media reports of a potential transaction.With the deal, the company said it would be \"better positioned to become the first choice for pharmacy, retail, and health services.\" It will continue to operate under Walgreens, Boots, and other brands and maintain its headquarters near Chicago.\"While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company,\" said CEO Tim Wentworth.With the sale of the VillageMD assets, the total deal consideration is a premium of up to 63% of Walgreens' share price on Dec. 9.Walgreens shares rose 5.7% in after hours trading on Thursday. They are up 13.6% this year on speculation that a t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4588":"碎股","BK4585":"ETF&股票定投概念","WBA":"沃尔格林联合博姿","BK4128":"药品零售","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD"},"translate_title":"沃尔格林确认240亿美元私有化交易--Barrons.com","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WBA":0.9},"content_text":"By Liz Moyer \n\n\n  Walgreens Boots Alliance has confirmed a $23.7 billion deal to be acquired by the private-equity firm Sycamore Partners. \n\n\n     The struggling drugstore chain operator said the deal is for $11.45 a share in cash, a 29% premium to its closing price on Dec. 9, before the first media reports of a potential transaction. \n\n\n     With the deal, the company said it would be \"better positioned to become the first choice for pharmacy, retail, and health services.\" It will continue to operate under Walgreens, Boots, and other brands and maintain its headquarters near Chicago. \n\n\n     \"While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company,\" said CEO Tim Wentworth. \n\n\n     Shareholders will receive the cash for shares plus up to $3 in cash per share representing the future sale of the company's debt and equity interests in VillageMD, a health clinic business that includes Village Medical, Summit Health, and CityMD. \n\n\n     With the sale of the VillageMD assets, the total deal consideration is a premium of up to 63% of Walgreens' share price on Dec. 9. \n\n\n     Walgreens shares rose 5.7% in after hours trading on Thursday. They are up 13.6% this year on speculation that a take-private deal was coming. The shares are down 49% over the past 12 months. \n\n\n     Write to Liz Moyer at liz.moyer@barrons.com \n\n\n     This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 18:15 ET (23:15 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}